LSI USA ’26 (the Emerging MedTech Summit) took place from 16 to 20 March 2026 at the Waldorf Astoria Monarch Beach Resort in Dana Point, California. Organized by Life Science Intelligence, the event brings together founders of growing medtech companies with investors, corporate partners and healthcare leaders from around the world each year.
The program combines pitches to investors, panel discussions with industry experts and, above all, one-on-one partnering meetings focused on areas such as cardiovascular devices, digital health and diagnostics. For growing medtech companies, LSI USA is one of the most effective ways to reach a broad network of relevant contacts in the U.S. market in a short period of time.
Seerlinq was represented at the event by our CEO Allan Böhm, who held a series of meetings with investors and potential partners and presented the company’s current direction in non-invasive monitoring of patients with heart failure.
Taking part in events like LSI USA is an important part of building relationships within the U.S. medtech ecosystem, and it opens doors to further partnerships that help us bring Seerlinq’s technology to new markets.